The addition of neutralizing anti-CD112R antibodies to human NK cells co-cultured with MDA, a human breast cancer cell line expressing CD112 and CD155, increased NK cell degranulation and production of IFN-γ [41]. The gene discussed is PVRIG; the disease is breast cancer.